AEON Biopharma, Inc.
- Last sale
- Nov 12, 2026 · -9.55%
- Market cap
- $8.08M
- 49.88M shares
- Filings
- 367
—
—
—Q2 2026N/M FY25 yoy
Q2 2026N/M FY25 yoy
FY 2025derivedN/M FY25 yoy
Q2 2026N/M FY25 yoy
Q2 2026+23,023.1% FY25 yoy
- $8.08M
- —
- —
- —
- -214.36%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $4,094,000 | reported | |
| FY 2024 | 2024-12-31 | $14,181,000 | reported | |
| FY 2022 | 2022-12-31 | $34,754,000 | reported |
Pharmaceutical preparations
AEON Biopharma, Inc. is the 432nd largest of the 554 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
AEMDAethlon Medical Inc———$8.8MRKTORocket One Inc.———$8.8MMTVAMetaVia Inc.———$8.6MCALCCalciMedica, Inc.———$8.6M
AEONAEON Biopharma, Inc. (this company)———$8.1M
VTGNVistagen Therapeutics, Inc.$1.3M161.1%5,491.3%$7.9MENSCEnsysce Biosciences, Inc.$5.1M2.8%200.8%$7.6MSNGXSoligenix, Inc.———$7.5MLTRNLantern Pharma Inc.———$7.4MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
AEON Biopharma, Inc. · CIK 1837607 · Engraved from SEC EDGAR